Literature DB >> 21699659

Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy.

Gregory A Broderick1.   

Abstract

INTRODUCTION: Priapism describes a persistent erection lasting longer than 4 hours. Ischemic priapism and stuttering priapism are phenotypic manifestations of sickle-cell disease (SCD). AIMS: To define the types of priapism associated with SCD, to address pathogenesis, and to recommend best practices. SOURCES: Literature review and published clinical guidelines. SUMMARY OF
FINDINGS: Priapism is a full or partial erection that persists more than 4 hours. There are three kinds of priapism: ischemic priapism (veno-occlusive, low flow), stuttering priapism (recurrent ischemic priapism), and nonischemic priapism (arterial, high flow). Ischemic priapism is a pathologic phenotype of SCD. Ischemic priapism is a urologic emergency when untreated priapism results in corporal fibrosis and erectile dysfunction. The recommended treatment for ischemic priapism is decompression of the penis by needle aspiration and if needed, injection (or irrigation) with dilute sympathomimetic drugs. Stuttering priapism describes a pattern of recurring unwanted painful erections in men with SCD. Patients typically awaken with an erection that persists for several hours and becomes painful. The goals of managing stuttering ischemic priapism are: prevention of future episodes, preservation of erectile function, and balancing the risks vs. benefits of various treatment options. The current molecular hypothesis for stuttering priapism in SCD proposes that insufficient basal levels of phosphodiesterase type-5 are available in the corpora to degrade cyclic guanosine monophosphate (cGMP). Nocturnal erections result from normal neuronal production and surges of cGMP. In the context of SCD stuttering priapism, these nocturnal surges in cGMP go unchecked, resulting in stuttering priapism.
CONCLUSIONS: Considering the embarrassing nature of the problem and the dire consequences to erectile function, it is important to inform patients, parents, and providers about the relationship of SCD to prolonged painful erections. Prompt diagnosis and appropriate medical management of priapism are necessary to spare patients surgical interventions and preserve erectile function.
© 2011 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21699659     DOI: 10.1111/j.1743-6109.2011.02317.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  17 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

3.  Resolution of Acute Priapism in Two Children With Sickle Cell Disease Who Received Nitrous Oxide.

Authors:  Michael H Greenwald; Colleen K Gutman; Claudia R Morris
Journal:  Acad Emerg Med       Date:  2019-08-01       Impact factor: 3.451

4.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

Review 5.  Pediatric sickle cell disease: past successes and future challenges.

Authors:  Emily Riehm Meier; Angeli Rampersad
Journal:  Pediatr Res       Date:  2016-10-05       Impact factor: 3.756

Review 6.  An adolescent with sickle cell anaemia experiencing disease-related complications: priapism and leg ulcer--a management challenge.

Authors:  Alexandra Vasconcelos; Ana Rita Prior; Anabela Ferrão; Anabela Morais
Journal:  BMJ Case Rep       Date:  2012-04-28

7.  Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Trinity J Bivalacqua; Hunter C Champion; Arthur L Burnett
Journal:  J Sex Med       Date:  2013-11-20       Impact factor: 3.802

Review 8.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

Review 9.  [Priapism: Current diagnostics and therapy].

Authors:  B Schwindl; T Bschleipfer; T Klotz
Journal:  Urologe A       Date:  2015-11       Impact factor: 0.639

10.  Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.

Authors:  Mina Cintho Ozahata; Grier P Page; Yuelong Guo; João Eduardo Ferreira; Carla Luana Dinardo; Anna Bárbara F Carneiro-Proietti; Paula Loureiro; Rosimere Afonso Mota; Daniela O W Rodrigues; André Rolim Belisario; Claudia Maximo; Miriam V Flor-Park; Brian Custer; Shannon Kelly; Ester Cerdeira Sabino
Journal:  J Sex Med       Date:  2019-10-24       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.